Compare Google Inc (GOOG) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Google Inc vs Recursion Pharmaceuticals Inc — how do they compare? Google Inc trades at $345.34 (market cap $4.20T), while Recursion Pharmaceuticals Inc trades at $3.36 (market cap $1.81B). The key difference: Google Inc is far larger — about 2320.4× Recursion Pharmaceuticals Inc's market cap, and Google Inc pays a 0.26% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| GOOG | RXRX | |
|---|---|---|
Market Cap | $4.20T | $1.81B |
Volume | 1,511,127 | — |
Sector | Technology | Health |
52-Week High | $399.06 | $6.79 |
52-Week Low | $200.19 | $2.84 |
Enterprise Value | $4.09T | $1.33B |
Dividend Yield | 0.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Google Inc
Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.
Read more on GOOG →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
